News
Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them
Poor investigator site selection remains a significant driver of spiraling costs and inefficiencies in clinical development.
Approval was based on data from the Phase III NextCOVE trial, which demonstrated that mNEXSPIKE met non-inferiority criteria ...
Major players including AbbVie, GSK, Sanofi, and Eli Lilly recently bolstered their R&D pipelines with a wave of acquisitions ...
Under terms of the deal, both companies will co-develop and co-commercialize BNT327 for multiple solid tumors, with the ...
A Harvard Business School Healthcare Alumni Association Q&A with Aileen Fernandes, Chief Business Officer of Arcellx.
The pharmaceutical company will donate money for each strike-out made by the team’s pitcher for the remainder of the regular ...
Lilly is also developing oral therapies for its gastroenterology pipeline.
The organization was inspired to promote awareness for the disease in the wake of the former President’s diagnosis.
In an effort to promote the use of genuine products, Novo Nordisk is offering a one-time first-month offer for Wegovy at $199 ...
The CDC Foundation is expanding a youth healthcare program to rural areas. Young people living in rural areas in Georgia, ...
Mercalis and PharmaCord announced the completion of their merger. The new company is rebranding itself as Valeris, which will ...
The organization is providing trainers with information and education for how to coach clients taking the weight-loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results